To verify the correct performance of MS-MLPA analysis, we developed an in-house methylation-specific ddPCR assay for CDH13. We confirmed increased levels of CpG methylation in the target site of the promoter region in tumor samples. This evidence concerns the gene CDH13 and neoplasm.